Crossmark

Re: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma after Nephrectomy

Crossref DOI link: https://doi.org/10.1016/j.eururo.2017.01.026

Published Print: 2017-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Klatte, Tobias
License Information

Text and Data Mining valid from 2017-05-01
More Information

This article is maintained by: Elsevier

Article Title: Re: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma after Nephrectomy

Journal Title: European Urology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eururo.2017.01.026

Content Type: simple-article

Copyright: © 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.